Osteonecrosis of the jaw (ONJ) is a serious complication for physicians prescribing bone resorption inhibitors to patients with osteoporosis. A session at the recent French Congress of Rheumatology ...

Osteonecrosis of the jaw is a condition where part of the jaw bone becomes exposed through the gums. This rare but potentially serious condition may happen after some oral surgery, like tooth removal, ...

Older women who received denosumab (Prolia, Amgen) for up to 10 years for osteoporosis had a low risk of osteonecrosis of the jaw (ONJ), although the risk was higher — albeit still quite small — if ...

A troubling jaw disease that may be related to the use of some of the most commonly used osteoporosis medications has been the subject of many news stories and law firm commercials lately. The disease ...

Patients with cancer who have taken bone-strengthening drugs should be on the lookout for osteonecrosis of the jaw. Bone-strengthening drugs are often prescribed to patients with multiple myeloma or ...

A humanized antibody used in cancer immunotherapy may be associated with a 44-year-old woman developing osteonecrosis of the jaw (ONJ). The case report was published on January 1 in Oral Surgery, Oral ...

BOSTON -- Osteonecrosis of the jaw (ONJ) is rare in patients taking the antiresorptive drug denosumab (Prolia), even when invasive dental procedures are performed, according to up to 8 years of data ...

Osteonecrosis of the jaw (ONJ) is a debilitating bone condition that affects the jaws and occurs as a result of reduced local blood supply to the bone. Today, experts released a research report that ...

Osteonecrosis of the jaw (ONJ) is a debilitating bone condition that affects the jaws and occurs as a result of reduced local blood supply to the bone. However, the literature involving ONJ -- ...